Bavarian Nordic expects to launch the chikungunya vaccine in both Switzerland and Canada in the first half of 2026. ”It will be an important growth factor for us,” says CFO.
发布者:BY ANJA HAUGE,转转请注明出处:https://robotalks.cn/competitor-crunch-and-new-markets-raise-bavarias-hopes-for-chikungunya-vaccine/